FI932654A - Hydroxamsyraderivat, som hindrar lipoxigenas - Google Patents

Hydroxamsyraderivat, som hindrar lipoxigenas Download PDF

Info

Publication number
FI932654A
FI932654A FI932654A FI932654A FI932654A FI 932654 A FI932654 A FI 932654A FI 932654 A FI932654 A FI 932654A FI 932654 A FI932654 A FI 932654A FI 932654 A FI932654 A FI 932654A
Authority
FI
Finland
Prior art keywords
lipoxigenas
hydroxamsyraderivat
hindrar
som
conditions
Prior art date
Application number
FI932654A
Other languages
English (en)
Other versions
FI932654A0 (fi
Inventor
Kazuo Ando
Takafumi Ikeda
Masami Nakane
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI932654A publication Critical patent/FI932654A/fi
Publication of FI932654A0 publication Critical patent/FI932654A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI932654A 1990-12-11 1993-06-10 Hydroxamsyraderivat, som hindrar lipoxigenas FI932654A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2415745A JPH06256285A (ja) 1990-12-11 1990-12-11 ヒドロキサム酸誘導体およびその用途

Publications (2)

Publication Number Publication Date
FI932654A true FI932654A (fi) 1993-06-10
FI932654A0 FI932654A0 (fi) 1993-06-10

Family

ID=18524043

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932654A FI932654A0 (fi) 1990-12-11 1993-06-10 Hydroxamsyraderivat, som hindrar lipoxigenas

Country Status (11)

Country Link
EP (1) EP0561882B1 (fi)
JP (1) JPH06256285A (fi)
AT (1) ATE110714T1 (fi)
CA (1) CA2094247A1 (fi)
DE (1) DE69103773T2 (fi)
DK (1) DK0561882T3 (fi)
ES (1) ES2059204T3 (fi)
FI (1) FI932654A0 (fi)
IE (1) IE63704B1 (fi)
PT (1) PT99729A (fi)
WO (1) WO1992010469A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5476873A (en) * 1990-07-25 1995-12-19 Abbott Laboratories Acetylene derivatives having lipoxygenase inhibitory activity
DK0540673T3 (da) * 1990-07-25 1997-03-24 Abbott Lab Acetylen-derivater med lipoxygenaseinhiberende virkning
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
US5288751A (en) * 1992-11-06 1994-02-22 Abbott Laboratories [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
US5342980A (en) * 1992-12-30 1994-08-30 American Cyanamid Company Fungicidal agents
GB9308652D0 (en) * 1993-04-27 1993-06-09 Wellcome Found Anti-inflammatory compounds
TW448144B (en) * 1993-08-19 2001-08-01 Pfizer Phenoxyphenyl cyclopentenyl hydroxyureas
JP2732504B2 (ja) * 1995-03-08 1998-03-30 農林水産省中国農業試験場長 アラキドン酸代謝活性阻害剤とその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0351214A1 (en) * 1988-07-14 1990-01-17 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives
EP0384594B1 (en) * 1989-02-03 1993-10-27 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives
CA2050597A1 (en) * 1989-03-30 1990-10-01 Dee W. Brooks Urea based lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
PT99729A (pt) 1992-11-30
IE63704B1 (en) 1995-05-31
JPH06256285A (ja) 1994-09-13
EP0561882B1 (en) 1994-08-31
CA2094247A1 (en) 1992-06-13
ES2059204T3 (es) 1994-11-01
FI932654A0 (fi) 1993-06-10
DK0561882T3 (da) 1994-10-03
WO1992010469A1 (en) 1992-06-25
IE914284A1 (en) 1992-06-17
DE69103773D1 (de) 1994-10-06
DE69103773T2 (de) 1994-12-15
EP0561882A1 (en) 1993-09-29
ATE110714T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
TW262461B (fi)
RU93004907A (ru) Производные гидроксамовой кислоты и n-гидроксимочевины. способ их получения фармацевтическая композиция и способ лечения
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE410160T1 (de) Fulvinsäure und deren verwendung in der behandlung von entzündungen
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
FI932654A (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
NO975726D0 (no) N-Hydroksyurea-derivater som anti-inflammatoriske midler

Legal Events

Date Code Title Description
FD Application lapsed